U.S. Markets close in 2 hrs 24 mins
  • S&P 500

    4,425.96
    +69.51 (+1.60%)
     
  • Dow 30

    34,639.79
    +342.06 (+1.00%)
     
  • Nasdaq

    13,886.36
    +347.07 (+2.56%)
     
  • Russell 2000

    2,034.67
    +30.64 (+1.53%)
     
  • Crude Oil

    87.41
    +1.81 (+2.11%)
     
  • Gold

    1,829.60
    -22.90 (-1.24%)
     
  • Silver

    23.78
    -0.12 (-0.49%)
     
  • EUR/USD

    1.1296
    -0.0010 (-0.0904%)
     
  • 10-Yr Bond

    1.7740
    -0.0090 (-0.50%)
     
  • Vix

    28.26
    -2.90 (-9.31%)
     
  • GBP/USD

    1.3519
    +0.0013 (+0.0946%)
     
  • USD/JPY

    114.3140
    +0.4480 (+0.3934%)
     
  • BTC-USD

    37,835.48
    +571.20 (+1.53%)
     
  • CMC Crypto 200

    867.46
    +11.65 (+1.36%)
     
  • FTSE 100

    7,469.78
    +98.32 (+1.33%)
     
  • Nikkei 225

    27,011.33
    -120.01 (-0.44%)
     

Ardelyx stock rockets again on massive volume, after plans to launch IBS-C treatment announced

·1 min read
Ardelyx stock rockets again on massive volume, after plans to launch IBS-C treatment announced
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • ARDX
  • ^GSPC

Shares of Ardelyx Inc. soared 27.2% on massive volume in midday trading Wednesday, and have now nearly doubled in two days since the company announced plans to launch its treatment for irritable bowel syndrome with constipation (IBS-C) in adults. Trading volume ballooned to 192.8 million shares, which was many multiples of the full-day average of 4.3 million shares, and enough to make the stock the most actively traded on major U.S. exchanges. The company said before Tuesday's open that it will